Jeanmonod Patrik 4
4 · Cytek Biosciences, Inc. · Filed Feb 22, 2024
Insider Transaction Report
Form 4
Jeanmonod Patrick
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-02-20+1,752→ 95,152 total - Tax Payment
Common Stock
2024-02-20$8.38/sh−683$5,724→ 94,469 total - Exercise/Conversion
Restricted Stock Units
2024-02-20−1,752→ 13,442 total→ Common Stock (1,752 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Represents the number of shares withheld by and surrendered to the Issuer on February 20, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
- [F3]The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.